Marie-Pierre Gourin

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Francine Garnache‐Ottou, Chrystelle Vidal, Sabeha Biichlé et al. · Blood Advances · 2019 · 121 citations · Full text

Medicine, Hematology, Oncology +17

Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup

Thomas Prébet, Sarah Bertoli, Xavier Thomas et al. · Blood · 2014 · 80 citations

Medicine, Hematology, Oncology +14

Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

Valeria Santini, Jennifer Schemenau, Alessandro Levis et al. · Blood · 2013 · 78 citations · Full text

Medicine, Hematology, Immunotherapy +6

A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failure

Marie Sébert, Aline Renneville, Cécile Bally et al. · Haematologica · 2019 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Ivosidenib Monotherapy Is Effective in Patients with IDH1 Mutated Myelodysplastic Syndrome (MDS): The Idiome Phase 2 Study By the GFM Group

Marie Sébert, Thomas Cluzeau, Odile Beyne Rauzy et al. · Blood · 2021 · 45 citations

Medicine, Hematology, Pharmacology +8